Components of the new GMP online monitoring system for sterile pharmaceutical companies
Time of Update: 2022-09-21
With the expansion of the influence of the FDA and EU GMP in China and the launch of a new version of GMP in China, the dynamic monitoring of the clean area environment of pharmaceutical companies, es
Under the intensive adjustment of major pharmaceutical companies, innovation is occupying an increasingly important position
Time of Update: 2022-09-09
In the industry's view, whether it is structural adjustment or personnel changes, multinational pharmaceutical companies are to better adapt to changes in the Chinese pharmaceutical market environment and focus on core business, especially in the field of innovative drugs.
Cash dividends, product reviews, senior executives leaving... The announcement of listed pharmaceutical companies on August 12 is interesting
Time of Update: 2022-08-20
Dirui Medical's 2022 semi-annual report shows that the company achieved operating income of 515 million yuan in the first half of the year, an increase of 23.
Pfizer recalls several batches of blood pressure drugs over carcinogen
Time of Update: 2022-05-14
According to Reuters, on April 22, the US pharmaceutical giant Pfizer announced that it would recall five batches of the antihypertensive drug "Akpril" .
Pfizer last month also recalled some batches and two authorized cheaper versions of another blood pressure drug, Accuretic, because it may contain carcinogens .
Industry: In the long run, the pharmaceutical industry is still a "long slope and thick snow" track
Time of Update: 2022-05-11
Specifically, the The fund manager believes that there are many investment opportunities in the field of innovative drugs and medical devices, because innovative products have strong explosive performance and are supported by logic such as independent innovation and import substitution .
Who is the "pillar" for the sales growth rate of big pharmaceutical companies
Time of Update: 2022-04-17
Recently, large multinational pharmaceutical companies have successively released their 2021 annual reports.
How is the growth of large pharmaceutical companies?
(Data sources: Annual reports of various companies, Huachuang Securities, Medical Cube, etc.
CSPC took the lead in buying the bottom, and the domestic Biotech selling tide is about to start
Time of Update: 2022-03-07
The inevitable result of the trend of the times Some people say that Mingkang Bio's "selling body" opened the prelude to the big pharmaceutical company's bottom-hunting Biotech, which is true .
The U.S. Department of Commerce announced that the sanctions list does not involve CXOs and innovative pharmaceutical companies
Time of Update: 2021-12-31
S. Department of Commerce issued a notice stating that dozens of entities located in China, Georgia, Malaysia, and Turkey were included in the Entity List, of which 34 Entities are located in China .
Statistical Guidelines for Clinical Research of Rare Disease Drugs (Draft for Solicitation of Comments) released
Time of Update: 2021-12-06
On November 18th, CDE drafted the "Guiding Principles for Clinical Research of Rare Disease Drugs (Draft for Comment)", which is now open for comment .
“Guidelines for Statistics of Clinical Research on Rare Disease Drugs (Draft for Comment)” feedback form for soliciting opinions
New type of decoction pieces or a big outbreak, the equipment industry will have a lot to do
Time of Update: 2021-10-10
The broken-wall decoction pieces break the plant cell wall through modern ultra-fine pulverization technology, and release the effective ingredients of traditional Chinese medicine so that the ingredients can be better absorbed by the human body.
Has a good opportunity for big pig farmers to enter the market for half a year after the hog futures is listed
Time of Update: 2021-08-03
DCE told a reporter from China Business Daily that the price of live pigs has fallen sharply since June, and the industry and companies have a better understanding of the role of the futures market.
Fuan Pharmaceutical's Rocuronium Bromide Injection passed the consistency evaluation of generic drugs
Time of Update: 2021-07-07
, a wholly-owned subsidiary of Fuan Pharmaceutical Group, had recently received a supplementary drug application approval notice issued by the National Medical Products Administration.
Its product rocuronium Ammonium injection passed the quality and efficacy consistency evaluation of generic drugs .
No need to change pregnancy risk data label GlaxoSmithKline wins Zofran safety lawsuit
Time of Update: 2021-06-11
Therefore, Judge Saylor believes that the FDA refused to add pregnancy warning labels in accordance with the obligations imposed on it by federal law, and the US federal law takes precedence over the plaintiff’s claim in state law that no safety warning has been issued.
How does the number and scale of public hospitals develop? The Health and Wellness Commission replied
Time of Update: 2021-03-24
According to the "Reply", the National Health Commission is studying and revising the national medical and health service system plan, scientifically determining the number, scale and layout of public hospitals and social hospitals, rationally adjusting the bed allocation standards of public hospitals, and supporting some powerful public hospitals On the basis of controlling the size of the single unit, appropriate construction and development of multiple hospitals, and rapid conversion of functions when a major epidemic occurs.
Antibiotic injection growth slides Carbon penicillin down 9% YoY
Time of Update: 2021-02-16
According to Minenet data, in the first three quarters of 2017, the amount of carbon penicillin antimicrobial drugs used in public hospitals in key cities in China was RMB1,666 million, resulting in a forecast of RMB2.332 billion for the whole of 2017, an increase of 4.80 percent year-on-year and a decrease of 9 percentage points year-on-year.